Sponsor Pipeline

Novartis Gene Therapies Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04042025 Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi Spinal Muscular Atrophy Type I Active, Not Recruiting
Not specified
NCT03421977 Long-Term Follow-up Study for Patients From AVXS-101-CL-101 Spinal Muscular Atrophy 1 Active, Not Recruiting
Disease Areas
Spinal Muscular Atrophy (2)
Get alerts when Novartis Gene Therapies's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free